期刊
ACS BIOMATERIALS SCIENCE & ENGINEERING
卷 8, 期 1, 页码 151-160出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsbiomaterials.1c01234
关键词
multifunctional nanoparticles; retinoblastoma; photothermal therapy; chemotherapy; NIR dye
资金
- MHRD
- Govt. of India [BT/NNT/28/1386/2017, 4291, DST/INSPIRE/04/2015/000377, DST/TDT/AMT/2017/227(G)]
- Vasudha foundations, Hyderabad
Retinoblastoma is a critical intraocular malignancy in children, and chemo/photothermal therapy with multifunctional polymeric nanoparticles (PNPs) entrapped with anticancer drug and near-infrared dye showed significant cytotoxic effect on retinoblastoma cells. In vivo studies in a mice model demonstrated optimal photoacoustic signals, suggesting the potential of this combined approach for retinoblastoma therapy.
Retinoblastoma (Rb) is the most critical and severe intraocular malignancy occurring in children. The clinical management of retinoblastoma is still challenging due to failure in early detection and control despite the advancements in medical strategies. Early-stage Rb tumors do not occupy major visual fields, so chemo/photothermal therapy (PTT) with biocompatible materials can be a practical approach. Herein, we report multifunctional polymeric nanoparticles (PNPs) entrapped with an FDA-approved anticancer drug, Palbociclib (PCB), and a near-infrared dye, IR820 (IR), as chemo/photothermal agents. These PCB/IR PNPs were evaluated for the combinational effect in the retinoblastoma cell line. Further, the in vivo photoacoustic imaging efficacy and acute toxicity profile of the PNPs were studied in a mice model. The results indicated that the PCB/IR PNPs exhibited a significant cytotoxic effect (86.5 +/- 2.3%) in Y79 cell lines than the respective control groups upon exposure to NIR light. Qualitative and quantitative analyses indicated that PCB/IR PNPs with NIR light induction resulted in DNA damage followed by apoptosis. PCB/IR PNPs, when tested in vivo, showed optimal photoacoustic signals. Thus, the combination of PCB and PTT can emerge as a translational modality for retinoblastoma therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据